Published in JAMA on December 23, 2009
Ginkgo Biloba Prevention Trial in Older Individuals | NCT00010803
Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift. Neuron (2011) 2.67
Treatment for mild cognitive impairment: systematic review. Br J Psychiatry (2013) 1.58
Differences in Alzheimer disease clinical trial outcomes based on age of the participants. Neurology (2015) 1.45
Neuropsychiatric symptoms and expenditure on complementary and alternative medicine. J Clin Psychiatry (2015) 1.41
Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress. Annu Rev Med (2013) 1.36
Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761) neuroprotection. Neuroscience (2011) 1.20
The diagnosis and management of mild cognitive impairment: a clinical review. JAMA (2014) 1.18
In vivo assessment of amyloid-β deposition in nondemented very elderly subjects. Ann Neurol (2013) 1.17
Nutrition and neurodegeneration: epidemiological evidence and challenges for future research. Br J Clin Pharmacol (2013) 1.15
Using genetics to enable studies on the prevention of Alzheimer's disease. Clin Pharmacol Ther (2012) 1.14
A new species of Scirtothrips infesting Ginkgo biloba in eastern China. J Insect Sci (2012) 1.13
Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia. Neurology (2013) 1.11
A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial. J Nutr Health Aging (2013) 1.00
Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail? Oxid Med Cell Longev (2014) 0.97
Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions. Alzheimers Res Ther (2010) 0.97
Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly. Neuropsychology (2013) 0.97
From single target to multitarget/network therapeutics in Alzheimer's therapy. Pharmaceuticals (Basel) (2014) 0.92
Assessing and treating forgetfulness and cognitive problems in adults with HIV. J Assoc Nurses AIDS Care (2013) 0.92
Nutrition and prevention of Alzheimer's dementia. Front Aging Neurosci (2014) 0.92
Oxidant/Antioxidant imbalance and the risk of Alzheimer's disease. Curr Alzheimer Res (2015) 0.92
Prospects for delaying the rising tide of worldwide, late-life dementias. Int Psychogeriatr (2010) 0.90
The LIFE Cognition Study: design and baseline characteristics. Clin Interv Aging (2014) 0.89
Lifestyle Activities in Sociodemographically at-risk Urban, Older Adults Prior to Participation in the Baltimore Experience Corps(®) Trial. Act Adapt Aging (2012) 0.89
Nutraceuticals in cognitive impairment and Alzheimer's disease. Front Pharmacol (2014) 0.87
Markers of cholesterol transport are associated with amyloid deposition in the brain. Neurobiol Aging (2013) 0.87
Herbal therapy: a new pathway for the treatment of Alzheimer's disease. Alzheimers Res Ther (2010) 0.86
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9. Support Care Cancer (2012) 0.85
Assessment of health claims, content, and safety of herbal supplements containing Ginkgo biloba. Food Nutr Res (2010) 0.85
Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer's disease. Transl Neurodegener (2013) 0.84
Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study. PLoS One (2014) 0.82
Anti-ischaemic effects of bilobalide on neonatal rat cardiomyocytes and the involvement of the platelet-activating factor receptor. Biosci Rep (2011) 0.82
Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies. Mol Neurobiol (2014) 0.80
Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood. J Neurooncol (2012) 0.79
Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old. Neurology (2014) 0.79
Gene by neuroticism interaction and cognitive function among older adults. Int J Geriatr Psychiatry (2012) 0.79
An update on the diagnosis and management of dementing conditions. Rev Neurol Dis (2011) 0.78
Toxicity and carcinogenicity studies of Ginkgo biloba extract in rat and mouse: liver, thyroid, and nose are targets. Toxicol Pathol (2013) 0.77
Natural products and supplements for geriatric depression and cognitive disorders: an evaluation of the research. Curr Psychiatry Rep (2014) 0.77
Associations Between Mild Cognitive Impairment and Hospitalization and Readmission. J Am Geriatr Soc (2015) 0.77
Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis. Climacteric (2015) 0.77
Prevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and Research. ISRN Nurs (2013) 0.77
DHA Supplementation Alone or in Combination with Other Nutrients Does not Modulate Cerebral Hemodynamics or Cognitive Function in Healthy Older Adults. Nutrients (2016) 0.77
Ginkgo biloba and cognitive decline. JAMA (2010) 0.76
Effect of ginkgo biloba on the pharmacokinetics of raltegravir in healthy volunteers. Antimicrob Agents Chemother (2012) 0.76
Huo-Luo-Xiao-Ling (HLXL)-Dan, a Traditional Chinese Medicine, for patients with osteoarthritis of the knee: a multi-site, randomized, double-blind, placebo-controlled phase II clinical trial. Osteoarthritis Cartilage (2015) 0.76
Herbal Extracts Combination (WNK) Prevents Decline in Spatial Learning and Memory in APP/PS1 Mice through Improvement of Hippocampal Aβ Plaque Formation, Histopathology, and Ultrastructure. Evid Based Complement Alternat Med (2012) 0.76
Self-Reported Sleep Apnea and Dementia Risk: Findings from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Trial. J Am Geriatr Soc (2016) 0.75
Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial. Neuropsychiatr Dis Treat (2017) 0.75
The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat Med (2016) 0.75
Common dietary supplements for cognitive health. Aging health (2012) 0.75
Sideritis spp. Extracts Enhance Memory and Learning in Alzheimer's β-Amyloidosis Mouse Models and Aged C57Bl/6 Mice. J Alzheimers Dis (2016) 0.75
Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategies. Ann Neurosci (2015) 0.75
Progress in complementary and alternative medicine research: Yale Research Symposium on Complementary and Integrative Medicine. Yale J Biol Med (2010) 0.75
Herbal Medicine for the Treatment of Vascular Dementia: An Overview of Scientific Evidence. Evid Based Complement Alternat Med (2016) 0.75
Bilobalide induces neuronal differentiation of P19 embryonic carcinoma cells via activating Wnt/β-catenin pathway. Cell Mol Neurobiol (2014) 0.75
A new clinical scale for the staging of dementia. Br J Psychiatry (1982) 21.77
The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry (1987) 19.45
Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report (2008) 19.25
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA (2008) 6.00
Ginkgo for memory enhancement: a randomized controlled trial. JAMA (2002) 4.51
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology (2008) 1.91
The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials (2006) 1.88
Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry (2005) 1.83
Disparities in cognitive functioning by race/ethnicity in the Baltimore Memory Study. Environ Health Perspect (2004) 1.77
Normal rates of forgetting of verbal and non-verbal material in Alzheimer's disease. Cortex (1987) 1.68
Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci U S A (2002) 1.51
Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). J Mol Cell Cardiol (1997) 1.44
Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology (2005) 1.43
Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev (2009) 1.41
Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clin Neuropsychol (2000) 1.40
The Alzheimer's Disease Assessment Scale. Int Psychogeriatr (1996) 1.37
Extracts of Ginkgo biloba and ginsenosides exert cerebral vasorelaxation via a nitric oxide pathway. Clin Exp Pharmacol Physiol (1997) 1.30
Recruitment of the elderly into a pharmacologic prevention trial: the Ginkgo Evaluation of Memory Study experience. Contemp Clin Trials (2006) 1.29
The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl) (2000) 1.29
Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J Clin Epidemiol (2003) 1.05
The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology (Berl) (2000) 1.02
Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study. Aging Ment Health (2009) 1.02
Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy. Clin Nutr (2004) 0.97
Alpha 2-adrenoceptor changes during cerebral ageing. The effect of Ginkgo biloba extract. J Pharm Pharmacol (1992) 0.87
Effect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clin Ther (1993) 0.86
Ginkgo biloba: specificity of neuropsychological improvement--a selective review in search of differential effects. Hum Psychopharmacol (2009) 0.85
[Activity of Ginkgo biloba extract on short-term memory]. Presse Med (1986) 0.84
Effect of Ginkgo biloba extract on beta-adrenergic receptors in different rat brain regions. Phytother Res (2002) 0.82
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol (2006) 11.23
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol (2008) 7.95
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA (2002) 6.72
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab (2005) 6.25
Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA (2008) 6.00
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain (2008) 5.89
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 5.55
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med (2005) 5.10
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85
Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol (2003) 4.82
Chronic traumatic encephalopathy in a National Football League player. Neurosurgery (2005) 4.67
Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology (2004) 3.94
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85
Vascular cognitive impairment. Lancet Neurol (2003) 3.73
Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66
Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry (2006) 3.61
Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2007) 3.61
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (2007) 3.55
Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc (2004) 3.52
Thyroid status, cardiovascular risk, and mortality in older adults. JAMA (2006) 3.50
Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc (2004) 3.43
Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke (2004) 3.26
A social model for health promotion for an aging population: initial evidence on the Experience Corps model. J Urban Health (2004) 3.18
NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet (2009) 3.18
Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol (2005) 3.10
Research evaluation and prospective diagnosis of dementia with Lewy bodies. Arch Neurol (2002) 3.07
The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry (2013) 3.06
Brain structure and obesity. Hum Brain Mapp (2010) 3.04
Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology (2003) 2.97
Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation (2007) 2.93
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci U S A (2005) 2.79
Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol (2009) 2.79
Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73
Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology (2009) 2.70
Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol (2003) 2.70
3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage (2006) 2.69
Dementia with Lewy bodies. Lancet Neurol (2004) 2.66
Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol (2009) 2.66
Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology (2013) 2.61
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke (2004) 2.50
C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation (2005) 2.48
Chronic traumatic encephalopathy in a national football league player: part II. Neurosurgery (2006) 2.40
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation (2006) 2.40
Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med (2013) 2.38
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (2007) 2.36
Subclinical brain magnetic resonance imaging abnormalities predict physical functional decline in high-functioning older adults. J Am Geriatr Soc (2005) 2.31
Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci (2008) 2.30
Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry (2006) 2.29
Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol (2004) 2.21
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology (2012) 2.19
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci (2005) 2.17
Associations of gait speed and other measures of physical function with cognition in a healthy cohort of elderly persons. J Gerontol A Biol Sci Med Sci (2007) 2.14
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A (2010) 2.12
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood (2009) 2.07
The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci (2003) 2.06
Experience Corps: design of an intergenerational program to boost social capital and promote the health of an aging society. J Urban Health (2004) 2.04
Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab (2006) 2.03
"Successful aging": effect of subclinical cardiovascular disease. Arch Intern Med (2003) 2.02
Serum amyloid P and cardiovascular disease in older men and women: results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (2006) 1.97
Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol (2003) 1.94
3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS. Neuroimage (2006) 1.93
Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol (2005) 1.92
Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. Neurology (2012) 1.91
Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol (2005) 1.91
White matter grade and ventricular volume on brain MRI as markers of longevity in the cardiovascular health study. Neurobiol Aging (2006) 1.88
The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials (2006) 1.88
Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS (2004) 1.84